R Factor for Liver Injury

ورودی‌های بالینی بیمار

حداقل ۱ — حداکثر ۲۰۰۰۰ • واحد: U/L

حداقل ۱ — حداکثر ۲۰۰ • واحد: U/L

حداقل ۱ — حداکثر ۱۰۰۰۰ • واحد: U/L

حداقل ۱ — حداکثر ۵۰۰ • واحد: U/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
r factor
—ratio
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Hepatocellular5–1000
  • Mixed2–5
  • Cholestatic0–2
Direct Clinical Answer

The R Factor for Liver Injury calculates evaluating end-stage liver disease severity, short-term mortality, and liver transplant waitlist prioritization. Key inputs include alt. Scores guide managing portal hypertension complications, referring for liver transplant evaluation, and supportive care. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Classifies drug-induced liver injury pattern: >=5 hepatocellular, 2-5 mixed, <=2 cholestatic.

Clinical Indication

The R Factor for Liver Injury is indicated for bedside clinical practice to support Classifies drug-induced liver injury pattern: >=5 hepatocellular, 2-5 mixed, <=2 cholestatic.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with decompensated liver cirrhosis, acute liver failure, portal hypertension, ascites, or end-stage liver disease awaiting organ allocation. Clinical application is indicated across Hepatology clinics, liver transplant assessment centers, gastroenterology wards, and liver ICUs.

Limitations & Contraindications

Due to muscle wasting and reduced hepatic creatine synthesis, serum creatinine routinely underestimates renal dysfunction in cirrhosis.

Clinical Pearls & Action Plan

Preventing spontaneous bacterial peritonitis (SBP), managing variceal hemorrhage, and monitoring hepatic encephalopathy are top clinical priorities.

Formula & Variables:

R = (ALT/ULN) / (ALP/ULN)

Input Parameters

NameTypeRequiredDescription
altfloatYesALT(U/L)
alt_ulnfloatYesALT upper limit of normal(U/L)
alpfloatYesAlkaline phosphatase(U/L)
alp_ulnfloatYesALP upper limit of normal(U/L)

Score Interpretation & Guidance

RangeStageDescription
5–1000HepatocellularHepatocellular injury pattern
2–5MixedMixed injury pattern
0–2CholestaticCholestatic injury pattern

Evidence-Based References (EBM)

  • Danan G, Benichou C. Causality assessment of adverse reactions to drugs. J Clin Epidemiol. 1993;46(11):1323-1330.

Related calculators